DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Kaufman PA, Awada A, Twelves C et al.
A phase III, open-label, randomized, multicenter study of eribulin mesylate versus capecitabine in patients with locally advanced or metastatic breast cancer previously treated with anthracyclines and taxanes. SABCS 2012; Abstr. S6-6.
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.